Home > Cashflow Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Cashflow Statement

AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹4.15 Cr₹7.35 Cr₹12 Cr₹5.19 Cr₹5.83 Cr
Adjustment ₹10 Cr₹7.59 Cr₹7.88 Cr₹5.50 Cr₹3.82 Cr
Changes In working Capital ₹7.55 Cr₹-5.28 Cr₹-14 Cr₹-0.80 Cr₹-23 Cr
Cash Flow after changes in Working Capital ₹22 Cr₹9.66 Cr₹5.08 Cr₹9.90 Cr₹-14 Cr
Cash Flow from Operating Activities ₹22 Cr₹9.48 Cr₹4.95 Cr₹9.73 Cr₹-14 Cr
Cash Flow from Investing Activities ₹-21 Cr₹-15 Cr₹-7.49 Cr₹-6.54 Cr₹-5.35 Cr
Cash Flow from Financing Activities ₹1.06 Cr₹-0.85 Cr₹10 Cr₹-4.81 Cr₹12 Cr
Net Cash Inflow / Outflow ₹2.04 Cr₹-6.41 Cr₹7.64 Cr₹-1.63 Cr₹-6.68 Cr
Opening Cash & Cash Equivalents ₹1.40 Cr₹7.81 Cr₹0.17 Cr₹1.80 Cr₹8.48 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹3.43 Cr₹1.40 Cr₹7.81 Cr₹0.17 Cr₹1.80 Cr

Compare Cashflow Statement of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹276.9 Cr -1.2% -23.6% 42.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-1.2%

-23.6%

42.8%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses